RxDoctor Payments Data

Anthony Barber, DO

Sleep Medicine · Boulder, CONPI 1376747444

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $6,288 of the $7,773 with a category attached, or 80.9%. Jazz Pharmaceuticals Inc. accounts for 94.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $7,380 and has fallen 97.3% since, to $200 in 2025. Among sleep medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,773in general payments, 2019–2025

Across 17 payments — averaging $457.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$7K
  • Avadel CNS Pharmaceuticals, LLC$200
  • Harmony Biosciences LLC$140
  • Medtronic$53
$762in research payments, 2019–2025

Across 1 payment — averaging $761.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$762

What the payments were for

  • Consulting fees$2003%
  • Speaking & faculty fees$6,28881%
  • Travel & lodging$77410%
  • Food & beverage$3715%
  • Education$1402%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,773 in reported general payments places this provider in the 95th percentile of 35 sleep medicine providers in Colorado.

See all sleep medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$373,453
Medicare patients
1,802
Services billed
3,042

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate20$371,619
BelsomraSuvorexant34$15,161
NuvigilArmodafinil12$12,909
Doxepin Hcl47$4,064
Gabapentin140$1,013
Zolpidem Tartrate27$596
Mirtazapine23$387
Armodafinil15$387
Pregabalin25$307
Trazodone Hcl45$255
Fluticasone Propionate13$170
Clonazepam36$135
Ropinirole Hcl15$134
RivastigmineRivastigmine Tartrate13$117
Venlafaxine Hcl ErVenlafaxine Hcl12$65

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Boulder

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →